MoneyWorks4Me

FDC - Quaterly Results

09 Aug 2023 Evaluate
The Revenue for the quarter ended  June 2023 of Rs. 5300.40 millions grew by 7.51 % from Rs. 4930.08 millions.An average growth of 48.66% was recorded for the quarter ended June 2023 to Rs. 1085.51  millions from Rs. 730.19 millions.Operating profit for the quarter ended June 2023 rose to 1497.90 millions as compared to 994.18 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 5300.40 4930.08 7.51 5300.40 4930.08 7.51 17770.32 15189.65 16.99
Other Income 297.84 193.99 53.53 297.84 193.99 53.53 539.12 787.34 -31.53
PBIDT 1497.90 994.18 50.67 1497.90 994.18 50.67 3084.87 3255.80 -5.25
Interest 10.38 6.96 49.14 10.38 6.96 49.14 40.39 30.48 32.51
PBDT 1487.52 987.22 50.68 1487.52 987.22 50.68 3044.48 3225.32 -5.61
Depreciation 95.88 93.17 2.91 95.88 93.17 2.91 387.58 370.81 4.52
PBT 1391.64 894.05 55.66 1391.64 894.05 55.66 2656.90 2854.51 -6.92
TAX 306.13 163.86 86.82 306.13 163.86 86.82 647.25 658.15 -1.66
Deferred Tax 1.13 -79.14 -101.43 1.13 -79.14 -101.43 -42.75 -21.85 95.65
PAT 1085.51 730.19 48.66 1085.51 730.19 48.66 2009.65 2196.36 -8.50
Equity 165.91 165.91 0.00 165.91 165.91 0.00 165.91 168.81 -1.72
PBIDTM(%) 28.26 20.17 40.14 28.26 20.17 40.14 17.36 21.43 -19.01
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..